Alzheimer’s condition (AD) is usually a progressive neurodegenerative condition that has a multifactorial etiology. A multitarget procedure that modulates multifaceted biological features might be more practical than an individual-target solution. Below, the therapeutic efficacy of blend procedure applying anti-Aβ antibody NP106 and curcumin analog TML-six compared to monotherapy was ... https://www.directivepublications.org/the-journal-of-molecular-biology/